Biochemistry, Insulin Metabolic Effects

Fundamentals

Cellular energy homeostasis depends on an interconnected network of metabolic pathways regulating the synthesis, storage, and breakdown of carbohydrates, lipids, and proteins, with insulin serving as a central regulator. Insulin synthesis and secretion occur in pancreatic β cells within the islets of Langerhans. The islets also contain α cells producing glucagon and δ cells secreting somatostatin. The islets of Langerhans form the endocrine pancreas, coordinating hormonal control of metabolism. The exocrine pancreas facilitates digestion through enzyme secretion.

Insulin exerts physiologic effects by binding to the insulin receptor, inducing receptor autophosphorylation and activation of kinase signaling cascades, including the PI3K–Akt and MAPK pathways. These signaling cascades regulate glucose uptake, glycogen synthesis, lipid synthesis, and protein metabolism. In the postprandial state, insulin promotes glucose uptake, glycogenesis, lipogenesis, and protein synthesis, while suppressing hepatic glucose production and lipolysis. During fasting, stress, or exercise, glucagon release stimulates glycogenolysis, gluconeogenesis, and lipolysis to maintain blood glucose levels.[4]

Carbohydrate metabolism includes the following processes:

• Glycolysis: Glucose breakdown for energy production
• Gluconeogenesis: Glucose synthesis from non-carbohydrate precursors
• Glycogenesis: Glycogen synthesis and storage
• Glycogenolysis: Glycogen breakdown and mobilization

Lipid metabolism encompasses the following:

• Lipogenesis: Fatty acid and triglyceride synthesis
• Lipolysis: Triglyceride breakdown for energy utilization

As mentioned, insulin secretion and activity are influenced by the actions of stress hormones, sleep, pregnancy, illness, and environmental factors. These factors modulate insulin sensitivity and overall metabolic balance, ensuring adequate energy supply under varying physiological conditions.[5]

Cellular Level

Insulin exerts its physiological effects through the activation of insulin receptor–dependent signaling pathways in multiple target tissues, including skeletal muscle, adipose tissue, vascular endothelium, cardiac muscle, and hepatic tissue. The downstream effects of insulin are tissue-specific and reflect the distinct metabolic functions of each organ. In skeletal muscle, adipose tissue, and cardiac muscle, insulin stimulates glucose uptake through the promotion of GLUT4 translocation to the plasma membrane, thereby enhancing intracellular glucose utilization. In vascular endothelium and the myocardium, insulin activates endothelial nitric oxide synthase, increasing nitric oxide production, promoting vasodilation, and improving tissue perfusion. In the liver, insulin suppresses hepatic gluconeogenesis and glycogenolysis while promoting glycogenesis and de novo lipogenesis, facilitating postprandial glucose storage.[6]

Insulin actions vary across tissues and metabolic states. In the fed state, elevated circulating insulin levels promote glucose utilization for immediate energy production while directing excess glucose toward anabolic pathways, including glycogen synthesis and lipogenesis. Coordinated processes support overall metabolic homeostasis.

Following a meal, the liver plays a central role in glucose metabolism through the extraction of glucose from the portal circulation. Hepatic glucose undergoes oxidation for adenosine triphosphate (ATP) production or conversion to glycogen via glycogenesis for storage. When glycogen stores approach capacity, excess glucose is metabolized into fatty acids, which are subsequently esterified into triglycerides and exported as very-low-density lipoproteins for storage in adipose tissue. Glucose also serves as a key precursor for biosynthetic pathways, contributing to the synthesis of fatty acids, nucleotides, and amino sugars required for cellular structure and function.[7]

In the central nervous system, glucose serves as the primary energy substrate. However, uptake is largely insulin-independent and mediated by glucose transporter types 1 (GLUT1) and 3 (GLUT3). Neurons oxidize glucose via glycolysis and oxidative phosphorylation to generate ATP and support neurotransmitter synthesis. Hypoglycemia impairs neuronal function, leading to clinical manifestations, such as confusion, dizziness, and lightheadedness.[8]

Red blood cells depend entirely on glucose as the sole energy source, as mitochondria are absent. Glucose metabolism in erythrocytes occurs via anaerobic glycolysis to generate ATP. In skeletal muscle, glucose undergoes glycolysis during exercise or stress to meet energy demands, while at rest, skeletal muscle stores glucose as glycogen via glycogenesis.

Adipose tissue utilizes glucose for ATP production and the generation of glycerol-3-phosphate, required for triglyceride synthesis. Insulin promotes lipid storage through the stimulation of lipogenesis and inhibition of lipolysis. In addition to its effects on carbohydrate and lipid metabolism, insulin enhances protein synthesis and inhibits proteolysis, contributing to overall anabolic balance.

In summary, circulating glucose concentrations increase in the fed state, stimulating pancreatic β cells to secrete insulin. The hormone facilitates glucose uptake in insulin-sensitive tissues and coordinates metabolic pathways that promote glucose utilization and storage, thereby restoring and maintaining euglycemia.

Molecular Level

Insulin is a peptide hormone synthesized in pancreatic β cells as preproinsulin, consisting of a signal peptide, B chain, C-peptide, and A chain. In the rough endoplasmic reticulum, cleavage of the signal peptide forms proinsulin, which undergoes folding and disulfide bond formation. Proinsulin is transported to the Golgi apparatus and packaged into secretory granules, where cleavage at dibasic residues occurs via prohormone convertases (PC1/3 and PC2) and carboxypeptidase E, producing insulin (A and B chains) and C-peptide. Insulin and C-peptide are secreted in equimolar amounts, making C-peptide a useful marker of endogenous insulin production and enabling differentiation between exogenous insulin administration and insulinoma. Insulin is stored in β-cell granules as zinc-coordinated hexamers and released in response to glucose stimulation.[9][10][11]

Function

Roles of Insulin in Metabolism

As mentioned, insulin exerts broad regulatory effects across multiple metabolic pathways. The most physiologically significant roles are outlined below.

Glucose metabolism

Glucose homeostasis is maintained through insulin-mediated glucose uptake and glucose-stimulated insulin secretion. Insulin increases glucose uptake in skeletal muscle and adipose tissue while decreasing hepatic glucose production.

Mechanistically, insulin binds to the α subunit of the insulin receptor and activates β-subunit tyrosine kinase activity. Activation of the receptor stimulates phosphorylation of insulin receptor substrates, resulting in activation of the PI3K–Akt pathway.

Key effects include increased GLUT4 translocation and enhanced glucose uptake in muscle and adipose tissue. GLUT4-mediated uptake is stimulated by insulin and exercise, with exercise representing an insulin-independent mechanism. Additional effects include increased glycogen synthesis and glycolysis, as well as reduced gluconeogenesis.

Glycogen metabolism

Insulin promotes glycogenesis and inhibits glycogenolysis in the liver (see Image. Glycogen Structure and Metabolism). Key enzyme regulation involves protein phosphatase 1. Dephosphorylation results in the activation of glycogen synthase. Dephosphorylation also results in the inactivation of phosphorylase kinase and glycogen phosphorylase. The net effects include increased glycogen synthesis and decreased glycogen breakdown.

Hepatic gene regulation

Insulin regulates hepatic gene expression by inhibiting gluconeogenesis through downregulation of phosphoenolpyruvate carboxykinase, fructose-1,6-bisphosphatase, and glucose-6-phosphatase. Glycolytic activity is increased through the upregulation of glucokinase and pyruvate kinase. Lipogenesis is also promoted through increased expression of fatty acid synthase, acetyl coenzyme A (acetyl-CoA) carboxylase, and pyruvate dehydrogenase.

Lipid metabolism

Insulin promotes fat storage and inhibits fat breakdown. In mechanistic terms, the hormone increases lipogenesis in the liver and adipose tissue. Insulin also increases glucose uptake, providing glycerol-3-phosphate for triglyceride synthesis. Hormone-sensitive lipase is inhibited via dephosphorylation. The net effect includes reduced circulating free fatty acids.

Protein metabolism

Insulin is an anabolic hormone that regulates protein metabolism. Insulin increases amino acid uptake, particularly alanine, arginine, and glutamine. Insulin also enhances protein synthesis in skeletal muscle and the liver. Proteolysis is decreased through the inhibition of the ubiquitin–proteasome pathway.

Effects on Vascular Function and Inflammatory Processes

Insulin exerts vasodilatory and anti-inflammatory effects through actions on the vascular endothelium and immune cells. In the vascular endothelium, insulin increases endothelial nitric oxide synthase activity, leading to increased nitric oxide production and subsequent vasodilation. Insulin also decreases nuclear factor kappa B (NF-κB) activation, resulting in reduced expression of adhesion molecules, including intercellular adhesion molecule 1 and E-selectin. In macrophages, insulin decreases nicotinamide adenine dinucleotide phosphate oxidase activity, leading to reduced production of reactive oxygen species. Insulin also decreases NF-κB signaling, resulting in reduced synthesis of proinflammatory cytokines, including tumor necrosis factor α, interleukins 6 and 8, monocyte chemoattractant protein 1, and matrix metalloproteinases.

Clinical Significance

Chronic hyperglycemia exerts widespread adverse effects on physiological systems and serves as a key contributor to the development of multiple metabolic diseases. Diabetes mellitus, the most prevalent, is defined as a chronic disorder resulting from either insufficient insulin production by the pancreas, as in type 1 diabetes mellitus (T1D), or ineffective utilization of insulin by target tissues, as in type 2 diabetes mellitus (T2D). These 2 types account for the majority of cases.[12][13]

Core Pathophysiology

The exact etiology of diabetes mellitus remains incompletely understood. Several factors correlate with increased disease prevalence, including genetics, lifestyle, and environmental exposures, such as certain viral infections.

Chronic hyperglycemia results from an imbalance between glucose entry into the circulation, including dietary intake and hepatic glucose production, and glucose uptake and utilization by insulin-dependent tissues. Key defects include decreased peripheral glucose uptake in skeletal muscle and adipose tissue, along with increased hepatic glucose production through gluconeogenesis and glycogenolysis.

T1D results from autoimmune destruction of pancreatic β cells, leading to absolute insulin deficiency. The pathogenesis is mediated by T cells and classified as type IV hypersensitivity. Serologic findings include anti-glutamic acid decarboxylase antibodies, anti-insulin antibodies, and anti–islet cell antibodies. Histopathology demonstrates insulitis, characterized by lymphocytic infiltration of pancreatic islets. Clinical features include polyuria, polydipsia, and weight loss, with increased risk of diabetic ketoacidosis (DKA).[14][15][16][17][18][19][20]

T2D is characterized by insulin resistance with relative insulin deficiency (see Image. Insulin Resistance Mechanism). Disease progression begins with insulin resistance in skeletal muscle and adipose tissue, followed by compensatory hyperinsulinemia and eventual β-cell exhaustion with reduced insulin secretion. Risk factors include obesity, particularly visceral adiposity, and genetic predisposition. Histologic findings include islet amyloid deposition composed of amylin. T2D is more commonly associated with hyperosmolar hyperglycemic state (HHS).

Major Complications

Major complications of diabetes mellitus include acute metabolic emergencies and chronic microvascular and macrovascular damage. Acute complications include DKA and HHS. DKA occurs primarily in T1D and results from absolute insulin deficiency, leading to increased lipolysis and ketone body production. The resultant accumulation of ketones produces high–anion gap metabolic acidosis. Clinical features include Kussmaul respirations, fruity breath odor due to acetone, and dehydration. HHS occurs primarily in T2D and is characterized by severe hyperglycemia without significant ketosis due to residual insulin activity sufficient to suppress ketogenesis. Severe dehydration and altered mental status are characteristic findings.

Chronic complications are classified as microvascular and macrovascular. Microvascular complications include diabetic retinopathy, characterized by microaneurysms and neovascularization; diabetic nephropathy, marked by mesangial expansion, glomerular basement membrane thickening, and Kimmelstiel–Wilson nodules; and diabetic neuropathy, typically presenting with a “glove and stocking” distribution of sensory loss. Macrovascular complications result from accelerated atherosclerosis and include coronary artery disease, cerebrovascular disease leading to stroke, and peripheral arterial disease.

Mechanisms of Chronic Complications

The pathogenesis of chronic complications involves multiple interrelated biochemical pathways contributing to tissue injury in chronic hyperglycemia. Advanced glycation end products result from nonenzymatic glycation of proteins, leading to cross-linking of collagen and subsequent thickening of basement membranes. Clinical effects include diabetic nephropathy, diabetic retinopathy, and accelerated atherosclerosis.

The polyol pathway involves the conversion of glucose to sorbitol via aldose reductase, followed by the transformation of sorbitol to fructose via sorbitol dehydrogenase. Several tissues lack sorbitol dehydrogenase activity, leading to sorbitol accumulation. In the lens, sorbitol trapping within the fibers contributes to cataract formation. In Schwann cells, sorbitol buildup plays a role in peripheral neuropathy. In the kidney, sorbitol retention is implicated in structural and functional damage.

Protein kinase C activation is triggered by chronic hyperglycemia and leads to increased vascular endothelial growth factor expression and greater vascular permeability, resulting in microvascular damage. Oxidative stress results from the increased production of reactive oxygen species, leading to endothelial dysfunction.

Clinical Impact

The increasing prevalence of diabetes mellitus is observed globally, driven primarily by rising obesity rates and an aging population. A substantial proportion of cases remain undiagnosed, contributing to delayed diagnosis and treatment. Diabetes mellitus is a major cause of blindness, end-stage kidney failure, and cardiovascular mortality.

Emerging Therapy

Emerging therapy includes stem cell–derived β cells aimed at restoring endogenous insulin production. Current limitations encompass immature insulin secretion, immune rejection, and poor vascular integration.